ublituximab

Summary

ublituximab is a type of chemical entity^[1]. ublituximab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (28 views/month).^[2]

Key Facts

• ublituximab's instance of is recorded as type of chemical entity^[3].
• ublituximab's CAS Registry Number is recorded as 1174014-05-1^[4].
• ublituximab's subclass of is recorded as chemical compound^[5].
• ublituximab's Guide to Pharmacology Ligand ID is recorded as 8920^[6].
• ublituximab's Freebase ID is recorded as /m/0h5292q^[7].
• ublituximab's UNII is recorded as U59UGK3IPC^[8].
• ublituximab's DrugBank ID is recorded as DB11850^[9].
• ublituximab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'ublituximab'}^[10].
• ublituximab's subject has role is recorded as monoclonal antibody^[11].
• ublituximab's World Health Organisation international non-proprietary name numeric ID is recorded as 9334^[12].
• ublituximab's WikiProjectMed ID is recorded as Ublituximab^[13].

Why It Matters

ublituximab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (28 views/month).^[2] ublituximab has Wikipedia articles in 6 language editions, a strong signal of global cultural recognition.^[14] ublituximab is known by 3 alternative names across languages and contexts.^[15]